Dynamic leader with extensive experience in management, client-oriented technical strategy, totaling over 20 years, with a focus on gene therapy. Successfully directed the development of the branded AAVion production platform at Biovian CDMO, making impactful decisions to establish advanced manufacturing processes. Actively shaped proposals for all AAV program leads, and signed programs with technical expertise. Explored and pursued business opportunities via technical and collaboration. Strong background in viral vector markets, and technical expertise in GMP-grade production methodologies. Prior joining Biovian developed and managed the operation of Virus Vector and Genome Editing Cores, closing 10–20 client projects annually and achieving a 20× budget increase at peak performance.